Grant S - Search Results

1

Small molecule inhibitors targeting cyclin-dependent kinases as anticancer agents.

Dai Y, Grant S. Dai Y, et al. Among authors: grant s. Curr Oncol Rep. 2004 Mar;6(2):123-30. doi: 10.1007/s11912-004-0024-3. Curr Oncol Rep. 2004. PMID: 14751090 Review.

2

Evidence of a functional role for the cyclin-dependent kinase inhibitor p21(WAF1/CIP1/MDA6) in the reciprocal regulation of PKC activator-induced apoptosis and differentation in human myelomonocytic leukemia cells.

Wang Z, Su ZZ, Fisher PB, Wang S, VanTuyle G, Grant S. Wang Z, et al. Among authors: grant s. Exp Cell Res. 1998 Oct 10;244(1):105-16. doi: 10.1006/excr.1998.4191. Exp Cell Res. 1998. PMID: 9770354 Free article.

3

Evidence for involvement of mitogen-activated protein kinase, rather than stress-activated protein kinase, in potentiation of 1-beta-D-arabinofuranosylcytosine-induced apoptosis by interruption of protein kinase C signaling.

Jarvis WD, Fornari FA Jr, Tombes RM, Erukulla RK, Bittman R, Schwartz GK, Dent P, Grant S. Jarvis WD, et al. Among authors: grant s. Mol Pharmacol. 1998 Nov;54(5):844-56. doi: 10.1124/mol.54.5.844. Mol Pharmacol. 1998. PMID: 9804619

4

The role of ceramide in the cellular response to cytotoxic agents.

Jarvis WD, Grant S. Jarvis WD, et al. Among authors: grant s. Curr Opin Oncol. 1998 Nov;10(6):552-9. doi: 10.1097/00001622-199811000-00013. Curr Opin Oncol. 1998. PMID: 9818235 Review.

5

The roles of signaling by the p42/p44 mitogen-activated protein (MAP) kinase pathway; a potential route to radio- and chemo-sensitization of tumor cells resulting in the induction of apoptosis and loss of clonogenicity.

Dent P, Jarvis WD, Birrer MJ, Fisher PB, Schmidt-Ullrich RK, Grant S. Dent P, et al. Among authors: grant s. Leukemia. 1998 Dec;12(12):1843-50. doi: 10.1038/sj.leu.2401222. Leukemia. 1998. PMID: 9844914 Review.

6

Dysregulation of the cyclin-dependent kinase inhibitor p21WAF1/CIP1/MDA6 increases the susceptibility of human leukemia cells (U937) to 1-beta-D-arabinofuranosylcytosine-mediated mitochondrial dysfunction and apoptosis.

Wang Z, Van Tuyle G, Conrad D, Fisher PB, Dent P, Grant S. Wang Z, et al. Among authors: grant s. Cancer Res. 1999 Mar 15;59(6):1259-67. Cancer Res. 1999. PMID: 10096557

7

Protein kinase C targeting in antineoplastic treatment strategies.

Jarvis WD, Grant S. Jarvis WD, et al. Among authors: grant s. Invest New Drugs. 1999;17(3):227-40. doi: 10.1023/a:1006328303451. Invest New Drugs. 1999. PMID: 10665476 Review.

8

Evidence of a functional role for the cyclin-dependent kinase inhibitor p21CIP1 in leukemic cell (U937) differentiation induced by low concentrations of 1-beta-D-arabinofuranosylcytosine.

Wang Z, Wang S, Fisher PB, Dent P, Grant S. Wang Z, et al. Among authors: grant s. Differentiation. 2000 Aug;66(1):1-13. doi: 10.1046/j.1432-0436.2000.066001001.x. Differentiation. 2000. PMID: 10997587

9

Interactions between 2-fluoroadenine 9-beta-D-arabinofuranoside and the kinase inhibitor UCN-01 in human leukemia and lymphoma cells.

Harvey S, Decker R, Dai Y, Schaefer G, Tang L, Kramer L, Dent P, Grant S. Harvey S, et al. Among authors: grant s. Clin Cancer Res. 2001 Feb;7(2):320-30. Clin Cancer Res. 2001. PMID: 11234887

10

The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells.

Cartee L, Wang Z, Decker RH, Chellappan SP, Fusaro G, Hirsch KG, Sankala HM, Dent P, Grant S. Cartee L, et al. Among authors: grant s. Cancer Res. 2001 Mar 15;61(6):2583-91. Cancer Res. 2001. PMID: 11289135

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,844 results

Search Page

Filters